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doi:10.1016/j.jmii.2011.01.008Background: The distribution and characterization of OXA-type carbapenemases in Acineto-
bacter sp in Taiwan has less been reported. The aim of the study was to investigate the
molecular epidemiology and OXA-type carbapenemase genes in a regional hospital in
Taiwan.
Methods: Imipenem-resistant Acinetobacter sp were collected between 2005 and 2007 in
a regional hospital. Genotyping was performed by pulsed-field gel electrophoresis. OXA-type
carbapenemase genes were determined by multiplex polymerase chain reaction (PCR) and
gene sequencing.
Results: A total of 136 isolates were collected. Fifty-six pulsotypes were identified. None of
the pulsotypes established predominance throughout the 3-year period. Multiplex PCR of
blaOXA genes showed that 99% (135/136) of the Acinetobacter sp possessed blaOXA51-like
genes. The coexistences of blaOXA51-like/blaOXA-23-like and blaOXA51-like/blaOXA-24-like were de-
tected in 19% (26/136) and 1% (2/136) of the isolates, respectively. Among blaOXA-23-like
gene-carrying isolates, two isolates (Pulsotypes 18 and 20) were found in 2006 and the
remainder (nZ 24), including Pulsotypes 27 (nZ 18), 29 (nZ 1), 52 (nZ 3), and 53
(nZ 2), were found in 2007. Sequencing performed on the 26 representative isolatesof Medical Laboratory Science and Biotechnology, Yuanpei University, No. 306, Yuanpei Street, Hsin-
m (M.-L. Liou).
an Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
40 M.-F. Lin et al.confirmed the presence of the blaOXA-23 carbapenemase gene. Analysis of the genetic
content of blaOXA-23 showed that these genes were presumably chromosomal and associated
with the upstream-located insertion sequence ISAba1.
Conclusions: The emergence and imminent widespread of blaOXA-23-carrying imipenem-
resistant Acinetobacter sp appeared in Taiwan during the period from 2006 to 2007.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
All rights reserved.Introduction
Carbapenem resistance in Acinetobacter baumannii is
increasingly reported and has become a significant public
health concern.1 This phenotypic observation is likely
associated with changes in porin proteins, development of
efflux pumps, modification of penicillin-binding proteins,
and production of b-lactamases.2 Among the four Ambler
classes of b-lactamase, Class B enzymes (metallo-b-lacta-
mase) and several Class D enzymes (carbapenem-hydro-
lyzing oxacillinase [CHDLs]) have been demonstrated to
produce resistance in this organism.3 Transmissible genes
encoding metalloenzymes are found in Acinetobacter sp
and have been associated with several carbapenem-resis-
tant outbreaks.4 However, resistance associated with
CHDLs is more widespread in Acinetobacter sp.3
Four groups of the Class D carbapenem-hydrolyzing
enzymes, including OXA-23-like, OXA-24-like, OXA-58-like,
and OXA-51-like enzymes, have been identified in A bau-
mannii.3 High-level carbapenem resistance because of the
expression of genes encoding CHDLs requires a strong
promoter like that providedby themobile insertion sequence
ISAba1.5 Emergence and widespread dissemination of OXA-
23, 24/40, and -58 carbapenemases among Acinetobacter sp
have been observed in Asia-Pacific nations.6 In fact,
outbreaks of multidrug-resistant A baumannii strains and
their associated resistance mechanisms have been demon-
strated in diverse geographic areas, including America,
Europe, and the Far East.1,7e9 However, the distribution and
characterization of OXA-type carbapenemases in Acineto-
bacter sp in Taiwan is still limited.10e13
The goal of this study was to determine the genetic basis
for imipenem-resistant Acinetobacter sp strains and blaOXA
gene-associated resistance over a 3-year period in
a regional hospital in Taiwan.
Methods
Setting and bacterial strains
Hsin-Chu general hospital is a regional teaching hospital with
699 ward beds and 43 intensive care unit beds located in
northern Taiwan. This study included all imipenem-resistant
Acinetobacter sp isolates from the clinical specimens of the
hospital wards from January 2005 to December 2007.
Identification and antimicrobial susceptibilities
The clinical strains of Acinetobacter sp were isolated and
identified with the Vitek system (Biomerieux Vitek Inc.,Hazelwood, MO, USA). Characterization of these blaOXA-23-
carrying isolates as A baumannii or Acinetobacter non-bau-
mannii was performed by one-tube multiplex polymerase
chain reaction (PCR) based on the method of Chen et al.14
Isolates identified as other Acinetobacter sp were identified
to the genomic species level by 16S-23S ribosomal DNA inter-
genic spacer sequence analysis.15 Susceptibilities to antimi-
crobial agents were determined by the disk diffusion method
in accordance with the guidelines of the National Committee
for Clinical Laboratory Standards 2006.16 Susceptibilities to
antimicrobial agents in blaOXA-23-carrying isolates were
further determined by the microdilution method in accor-
dance with the guidelines of CLSI 2005.17 Escherichia coli
ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were
used as reference strains in susceptibility testing. All imipe-
nem-resistant Acinetobacter sp in the study were stored at
70C in trypticase soy broth (Difco Laboratories, Detroit,
MI, USA) supplemented with 20% glycerol until they were
tested.
Strain typing
Pulsed-field gel electrophoresis (PFGE) was performed on
genomic DNA of all the imipenem-resistant Acinetobacter
isolates as previously described.18 Chromosomal DNA plugs
were incubated with ApaI endonuclease. Restriction frag-
ments were separated by PFGE in 1% SeaKem Gold agarose
and run in 0.5 Tris-borate-EDTA buffer on a CHEF Mapper
XA system (Bio-Rad Laboratories, Hercules, CA, USA). The
initial switch time was 7 seconds; the final switch time was
40 seconds, and the run time was 22 hours at 6 V/cm. The
gel was stained with ethidium bromide, washed in distilled
water, and photographed under ultraviolet light. The PFGE
banding patterns were interpreted according to previously
described criteria.19 Saved tiff files of the photographed
gels were further analyzed with Molecular Analyst 1.6
software (Bio-Rad). Percent similarities were identified on
a dendrogram derived from the unweighted pair-group
method with arithmetic means based on Jaccard coeffi-
cients. Both band position tolerance and optimization were
set at 1.0%. Isolates with PFGE band similarity > 80% were
classified as the same type.
PCR amplification and sequencing
Multiplex-PCR amplification for the detection of blaOXA-23-like,
blaOXA-24-like, blaOXA-51-like, and blaOXA-58-like genes were
performed as previously described.20 For PCR detection
of ISAba1 genes, a set of primers, ISAba1A and ISAba1B,
were used as previously described.21 The genetic elements
carrying the blaOXA-51-like genes were investigated by PCR
Imipenem-resistant Acinetobacter sp carrying blaOXA-23 genes in Taiwan 41mapping using ISAba1 forward/OXA-51-like reverse primers,
whereas the genetic elements carrying the blaOXA-23-like genes
were investigated using ISAba1 forward/OXA-23-like reverse
primers.
To completely identify the carbapenemase genes in
blaOXA-23-like-carrier isolates, primers for the blaOXA-23-like
gene, oxacillinase, were used to amplify the entire blaOXA
gene from a genomic DNA template.8 The amplification
product was purified using Clean/Gel Extraction kit (BioKit,
Moali, Taiwan). DNA sequencing was performed by an ABI
3730 XL DNA Analyzer (Applied Biosystems, Foster city, CA,
USA). DNA sequenceswerecomparedwith those registered in
the National Centre for Biotechnology Information database.
To determine the location of blaOXA-23-like gene, genomic
and plasmid DNA extraction was performed using a plasmid
and chromosome purification kit (Viogene, Taipei, Taiwan).
Eluted chromosomal and plasmid DNA extracts were sub-
jected to PCRs specific for blaOXA-23-like genes or the 16S-23S
rRNA amplicon as previously described.15Results
A total of 136 imipenem-resistant Acinetobacter sp were
collected fromJanuary2005 toDecember 2007.These isolates
were found to be coresistant to other commonly used anti-
microbial agents, including piperacillin, piperacillin-tazo-
bactam, ampicillin/sulbactam, imipenem, ceftazidime,
gentamicin, amikacin, tetracycline, chloramphenicol, cipro-
floxacin, and co-trimoxazole by the disk diffusion method.
Genotyping showed that a total of 56 different pulsotypes
were identified during the 3-year period (Table 1). Except for
Pulsotype 38, which appeared in 2005 and 2007, none of the
other types were distributed over the 3-year period. The
percentage of imipenem-resistant Acinetobacter sp with one
pulsotype containing more than six isolates was 36% (16/45),
35% (18/52), and 46% (18/39) during 2005, 2006, and 2007,
respectively (Table 1).Table 1 Pulsotypes of imipenem-resistant Acinetobacter sp fro
Year No. of isolates Pulsotypes
2005 45 2, 30e38, 40e46,
48, 50, 55e56
2006 52 1, 3e22
2007 39 23e29, 38e39,
47, 49, 51e54PCRs for detection of four types of blaOXA genes were
performed with all 136 isolates. The blaOXA-51-like gene was
the most prevalent, being detected in 99% (135/136) of the
isolates. In 2005 and 2006, none of imipenem-resistant
Acinetobacter sp carrying blaOXA-24-like genes were identi-
fied and only two isolates carried blaOXA-23-like genes (Pul-
sotypes 18 and 20). The results of blaOXA containing
imipenem-resistant Acinetobacter sp in 2007 are presented
in Fig. 1. Figure 1 reveals 24 blaOXA-23-like-carrying isolates,
including Pulsotype 27 (nZ 18), 29 (nZ 1), 52 (nZ 3), and
53 (nZ 2) and two blaOXA-24-like-carrying isolates (Pulso-
types 28 and 51). Overall, the coexistence of blaOXA51-like/
blaOXA-23-like and blaOXA51-like/blaOXA-24-like was detected in
19% (26/136) and 1% (2/136) of the collected isolates,
respectively. No strain contained blaOXA-58 genes over the 3
years. All the blaOXA-23-like gene-carrying isolates were
identified as A baumannii according to the presence of
internal 208-bp fragment from the intergenic spacer region
as previously described by Chang et al.15 The entire blaOXA-
23-like gene product was determined in the 26 blaOXA-23-like
gene-carrying isolates. Twenty-five of these showed 100%
similarity to the blaOXA-23 gene product (Gene bank acces-
sion no. ACJ39922). One showed a frame-shift mutation in
the blaOXA-23 gene reading frame.
Minimal inhibitory concentrations of seven b-lactam
drugs for blaOXA-23 gene-carrying A baumannii strains were
shown in Table 2. All the isolates were shown to be non-
susceptible to those drugs. Seven of 26 isolates showed
lower minimal inhibitory concentration values among
pipericillin/tazobactam, ceftriaxone and ceftazidime. One
of the isolates with blaOXA-23-mutated gene showed resis-
tance to all the b-lactam drugs.
All 136 isolates contained the insertion sequence ISAba1.
The presence of the insertion sequence ISAba1, upstream
of a carbapenemase gene, reportedly can affect gene
expression and contingent resistance.5 To determine if this
association was true in our isolates, 39 isolates collected
from 2007 were screened by PCR for linkage of ISAba1 tom 2005 to 2007





















Figure 1. Pulsed-field gel electrophoresis profiles of ApaI-digested genomic DNA from imipenem-resistant Acinetobacter isolates
collected during 2007. Polymerase chain reaction results of blaOXA, ISAba1, ISAba1-blaOXA-51, and ISAba1-blaOXA-23 gene amplicons
for each isolate is given from the third to the sixth column.
42 M.-F. Lin et al.blaOXA. ISAba1 was present upstream of all blaOXA-23 genes.
However, the linkage of ISAba1 and OXA-51 was only
observed in 10 of 39 isolates (Fig. 1). Although 24 isolates
possessed both blaOXA-51 and blaOXA-23 genes, only ISAba1-
OXA-23 gene fragments could be detected in these isolates.
The genetic location of the blaOXA-23 gene was investi-
gated in the 26 isolates collected between 2006 and
2007. Plasmid DNA and genomic DNA were extracted from
blaOXA-23-carrying isolates and were screened by PCR using
primers for the 16S-23S rRNA and blaOXA-23 genes. Both 16S-
23S rRNA and blaOXA-23 PCR fragments could be detected in
chromosomal fractions but not in plasmid fractions in allTable 2 MICs of b-lactam drugs for blaOXA-23 gene-carrying A b









a One of the isolates contained blaOXA-23 mutated gene.
AMZ ampicillin; CZZ cefazolin; CTZZ ceftazidime; CTXZ ceftriax
SAMZ ampicillin-sulbactam; TZPZ piperacillin/tazobactam.blaOXA-23-carrying isolates. This shows that blaOXA-23 genes
are presumably chromosomal.
Discussion
The spread of imipenem-resistant A baumannii in hospital
outbreaks has been recently documented.8,10,22,23 Qi et al.8
reported that a single genotype of carbapenem-resistant
A baumannii established predominance in one tertiary
hospital between 2004 and 2007. Whereas, Lu et al.10










one; IPMZ imipenem; MICZminimal inhibitory concentration;
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types in a medical center in southern Taiwan during
a 2 1/2-year period. In another study conducted in several
Chinese hospitals, clonal spread of imipenem-resistant Aci-
netobacter sp has been found among different wards and
different hospitals.23 However, this study revealed that
there were diverse PFGE genotypes in our regional hospital
during the 3-year study period. Also, there were no wide-
spread imipenem-resistant Acinetobacter sp outbreaks
during this time period. Although no predominant clone was
found during this period, clonal spread did occur on a small
scale. Thiswas likely because of patient transfer andhospital
staff contact as suggested by Marchaim et al.24 Because of
the minimal clonal spread, it was failed to be noticed at the
time by health care workers.
Outbreaks because of Acinetobacter sp clones producing
OXA-23 carbapenemase have been reported in several
countries.23,25e27 Zhou et al.25 reported that 94.2% of imi-
penem-resistant A baumannii isolates from China harbored
blaOXA-23. Wang et al.
23 described that 97.7% and 4.1% of
carbapenem-resistant Acinetobacter sp isolates harbored
blaOXA-23 and blaOXA-58 in 2007, respectively. The SENTRY
surveillance program report showed that the distribution of
OXA-type genes, among Acinetobacter sp isolates in Asia-
Pacific nations, was made up mostly by blaOXA-23, whereas
blaOXA-24/40 and blaOXA-58 were less common.
6 In addition,
clonal dissemination was found among different medical
centers located in different countries in the Asia-Pacific
region. However, their study revealed that blaOXA-23 was
not found in the isolates recovered from Taiwan.6 Another
two studies conducted in Taiwan also reported that less
than 3% of carbapenem-resistant Acinetobacter sp isolates
carried blaOXA-23.
9,15 In this study, we found that 19% of the
collected isolates carried blaOXA-23, 69% (18/26) of which
belonged to the same type (Pulsotype 27). The implications
of this finding were that there was the potential for an
insidious clonal dissemination in our hospital between 2006
and 2007, and the increasing percentage of OXA-23 in OXA-
type carbapenemases in Acinetobacter sp deserves further
attention in Taiwan.
ISAbal,which isadjacent toblaOXA, playsamajor role in the
development of resistance to carbapenem.5 All 2007 isolates
in this study were PCR positive for ISAba1 (Fig. 1). Only one
isolate (0716) was PCR negative for all blaOXA genes. In addi-
tion, two of the blaOXA-51-like-carrying isolates (0720 and 0729)
were PCR negative for ISAba1-OXA-51. Therefore, the resis-
tance to imipenem in our isolates might bemediated by other
mechanisms.2 In the isolates that were PCR positive for both
blaOXA-23-like and blaOXA-51-like genes, ISAba1 was only associ-
ated with blaOXA-23-like genes. This implies that the expression
of these two genes might be associated with different
promoters. This result was in accordance with the finding by
Turton et al.5
The presence of blaOXA-23 in six different pulsotypes
from different wards at different times suggested the
capability for gene transfer within our isolates. Conjugative
plasmids may be important vectors that allow for the
transfer of antimicrobial resistance in Acinetobacter sp.28
Supporting this idea, blaOXA-23 has been reported to be
plasmid borne.3,29 However, this study found that the
plasmid profiles were not detected in our imipenem-resis-
tance Acinetobacter sp isolates. One possible explanation isthat larger plasmid could not be successfully purified by the
purification kit. Moreover, the purification process of
chromosome genes might be contaminated with plasmid.
Although the exact location of blaOXA-23 could not be
determined, we suggested that the genes were presumably
chromosomal located, which was consistent with the find-
ings of two previous studies.24,30 The exact location of
blaOXA-23 genes would be determined in the future.
Some patients in this study were the source of multiple
isolates. This may overestimate the status of blaOXA-23
dissemination in our regional hospital and disturb the
analysis of pulsotypes. Despite this limitation, the results of
this study demonstrate that emergence and imminent
widespread of OXA-23-producing imipenem-resistant Aci-
netobacter sp appeared in Taiwan during the period from
2006 to 2007.Acknowledgments
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